1043 High Matrix (1024x1024) MDCT Scan for the Evaluation of Airways and Lung Parenchyma in the Ovalbumin-Sensitized Murine Asthma Model: Comparison Between Methacholine and OVA Challenge

Wednesday, 14 October 2015
Hall D1 Foyer (Floor 3) (Coex Convention Center)

Boram Bae , Institute of Allergy and Clinical Immunology, Seoul National University Medical Research Center, seoul, South Korea

Sujeong Kim, MD , Institute of Allergy and Clinical Immunology, Seoul National University Medical Research Center, Seoul, South Korea

Han-Ki Park, MD , Institute of Allergy and Clinical Immunology, Seoul National University Medical Research Center, Seoul, South Korea

Hyun Seung Lee , Institute of Allergy and Clinical Immunology, Seoul National University Medical Research Center, Seoul, South Korea

Jae Woo Jung , Internal Medicine, Chung-Ang University Hospital, Seoul, South Korea

Chang Hyun Lee , Department of Radiology and Institute of Radiation, Seoul National University College of Medicine, South Korea

Hye-Ryun Kang, MD, PhD , Division of Allergy and Clinical Immunology, Department of Internal Medicine, Seoul National University Hospital, Seoul, South Korea

PURPOSE: Respiratory-gating and increased radiation dose with prolonged scan time in the use of Micro-CT have been difficult in asthma mouse model studies. The purpose of this study was to investigate the usefulness of 1024 matrix MDCT scan for the evaluation of in vivo airway and lung parenchymal changes without respiratory gating in the wild type mice and to compare the changes between OVA and methacholine challenge in the ovalbumin sensitized mice.

METHOD AND MATERIALS: We used a 128-MDCT scanner providing 1024 x 1024 matrix (Ingenuity, Philips Healthcare). CT scan was performed in 10 wild type mice and two radiologists analyzed the quality of airway images in each corresponding generation illustrated by the micro-CT scan in addition to the cardiac and respiratory motion artifacts. Five OVA-sensitized C57BL/6 mice were challenged with OVA and other five mice were challenged with methacholine. The airway inner area was measured in the mid-trachea and left main bronchus. The degree of peribronchial inflammation was graded by the consensus of two radiologists in the five lobes.

RESULTS: The 1024x1024 matrix MDCT scan showed comparable image quality and airway depiction to the micro-CT. Among twenty four airways, trachea, LMB1, LBA2, LMB2, RMB1, RMB2, CaRMB3, CaRMB4, CaRMB5, MiRMB3 and AcRMB3 were 100% depicted; LBB3, LMB3, LMB4, CrRMB2, CaRBA4 in 90%; LBC4, CrRBA3, CrRMB3, CrRBB4 in 80%; LMB5, CrRMB4 in 70%; CrRBA4 in 60%; and LBA3 in 50% (k = 0.89). The motion artifact was not seen in all mice but cardiac motion artifact was seen in 60% but 83.3% was mild degree and 16.7% was moderate. The trachea showed decreased inner area after methacholine challenge after 5 minutes (p<0.05) but OVA challenge did not show significant changes in both trachea and LMB. Methacholine challenge showed no parenchymal changes in the lungs but OVA challenge showed peribronchial GGO or consolidation in 60% (3/5).

CONCLUSION: High matrix MDCT showed excellent quality of airway visualization with high agreement between readers. While tracheal inner area was significantly decreased after methacholine challenge, peribronchial inflammation was seen only in the case of OVA challenge in ovalbumin-sensitized mice.